References
- Anichini M., Gargano N., Leonetti G. Sul meccanismo dell'attivita' ipotensiva dei diuretici: Influenza sulla pressione arteriosa della riduzioni del volume plasmatico indotte dal triamterene. Boll. Soc. ital. Biol. sper. 1963; 39: 803
- Baba W. I., Tudhope C. R., Wilson C. M. Site and mechanism of action of the diuretic, triameterene. Clin. Sci. 1964; 27: 181
- Cranston W. I., Semmence A. M., Richardson D. M., Barnett C. F. Effect of triamterene on elevated arterial pressure. Amer. Heart J. 1965; 70: 455
- Gregersen M. I., Chien S. Determination of body fluid volumes. Physical Techniques in Biological Research, W. L. Nastuk. New York Academic Press. 1964; Vol. 4: 1–115
- Heath W. C., Freis E. D. Triamterene and hydrochlorothiazide in the treatment of hypertension. J. Amer. med. Ass. 1963; 186: 119
- Krogsgård A. R., Kragh P. L. Triamteren. Et kaliumsparende diureticum. Kliniske under-søgelser hos patienter med ødemer. Ugeskr. Læg. 1964; 126: 298
- Leth A. Changes in plasma and extracellular fluid volumes in patients with essential hypertension during long-term treatment with hydrochlorothiazide. Circulation 1970; 42: 479
- Leth A., Binder C. The distribution volume of 82Br—as a measurement of the extracellular fluid volume in normal persons. Scand. J. clin. Lab. Invest. 1970; 25: 291
- Morin Y., Turmel L., Fortier J. Triamterene: clinical studies in arterial hypertension. Amer. Heart J. 1965; 69: 195
- Pippig L., Schmitt W., Buck R. Triamteren (2, 4, 7-Triamino-6-Phenylpteridin) in der Behandlung der essentiellen Hypertonie. Arzneimittel.-Forsch. 1965; 15: 285
- Rowe G. G., Afonso S., Castillo C. A., Lowe W. C., Crumpton C. W. Systemic and coronary hemodynamic effects of triamterene (2, 4, 7, triamino-6-phenyl pteridine). Proc. Soc. exp. Biol. (N. Y.) 1962; 110: 27
- Simpson F. O., Waal H. J. Clinical trial of triamterene in hypertensive patients. N. Z. med. J. 1964; 63: 199
- Spiekerman R. E., Berge K. G., Thurber D. L., Gedge S. W., McGuckin W. F. Potassium-sparing effects of triamterene in the treatment of hypertension. Circulation 1966; 34: 524
- Tarazi R. C., Dustan H. P. Ø., Frohlich E. D. Long-term thiazide therapy in essential hypertension: evidence for persistent alteration in plasma volume and renin activity. Circulation 1970; 41: 709